spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MONARCH 2 

 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jul 2017
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Apr 2017
Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2017
Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study of Abemaciclib Met Primary Endpoint of Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Aug 2016
Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Apr 2011
American Shared Hospital Services Announces Contract to Supply a Gamma Knife Perfexion System to Lovelace Medical Center in Albuquerque
Devices Oncology
 HSMN NewsFeed - 7 Mar 2011
American Shared Hospital Services Announces Upgrade to Gamma Knife Perfexion System
Devices Oncology Neurosurgery
 HSMN NewsFeed - 2 Nov 2010
American Shared Hospital Services Announces Contract to Supply a Leksell Gamma Knife Perfexion System to Fort Sanders Regional Medical Center in Knoxville
Devices Oncology Neurosurgery
 HSMN NewsFeed - 4 Feb 2010
American Shared Hospital Services Announces Contract to Supply a Leksell Gamma Knife Perfexion System to Methodist Hospital in San Antonio
Devices Oncology Neurosurgery
 HSMN NewsFeed - 27 May 2009
American Shared Hospital Services Announces Contract to Supply a Leksell Gamma Knife Perfexion System to Smilow Cancer Hospital at Yale-New Haven
Devices Oncology
 HSMN NewsFeed - 12 Feb 2009
American Shared Hospital Services to Develop Proton Beam Radiation Therapy Facility in San Francisco Bay Area
Devices Radiology
 HSMN NewsFeed - 10 Oct 2008
American Shared Hospital Services to Develop Proton Beam Radiation Therapy Facility at Long Beach Memorial Medical Center
Devices Oncology
 HSMN NewsFeed - 31 Mar 2008
American Shared Hospital Services Contracts to Supply a Leksell Gamma Knife Perfexion System to USC University Hospital
Devices Oncology Neurosurgery
 HSMN NewsFeed - 30 Oct 2007
Accuray Enters Partnership with Still River Systems
Devices Oncology
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.